|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 4 June 2021, 15:50. The announcement is not marked as price sensitive, and is 1 page(s) in length and 201.14kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.017% short sold according to ASIC data. It was ranked the 549th most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Addendum to Appendix 4C | 4 June 2021, 15:50 |
| Jefferies Healthcare Conference Presentation | 2 June 2021, 8:20 |
| Jefferies Healthcare Conference Webcast Link | 27 May 2021, 11:23 |
| Synthetic formulation in pending global PIII Trial | 20 May 2021, 11:26 |
You must be logged in to post a reply.
Medlab Clinical 